In a recent BioValley feature, Amin Rostami, CSO & SVP of R&D at Certara, shares how Certara empowers Chinese pharmaceutical companies from early research to regulatory submissions, paving the way for global success. By collaborating with academia, research centers, and regulators in China, Certara advances regulatory science and fuels innovation.
With over 25 years of PBPK expertise and 15+ years in QSP, Certara proudly partners with China’s leaders in pharmaceutical development.
Learn how Simcyp PBPK is transforming clinical pharmacology predictions and innovating drug development.